Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
aylo's goal is to expedite the shift toward a circular economy. With £22 million in annual recurring revenue, backing from venture capital, and certification as a B Corp, their technology platform facilitates the leasing and reusing of consumer products, making sustainability more accessible and affordable. Raylo recognizes that consumers and retailers will embrace this transition if it's both cost-effective and straightforward.
days to go:
Expired
investment:
£1,282,150
iDal is an employer platform on a mission to disrupt the inefficient talent management world. The company argues that the talent management industry is outdated and resistant to new technologies, increasing frustration for talent and clients. iDal aims to change this. It has onboarded over 300 talented models to date, including one of the world's top 50 models Ajak Deng and influencers such as @Saufeeya on its portal. It has also worked with notable names in fashion like Vogue, Burberry, Urban Outfitters, etc. The company asserts that its platform allows one agent to do the job of five, reducing the time spent on admin and negotiation, boosting an agent's ability to nurture talent and deliver the best client service. iDal is seeking an investment of £400,000 to invest in promoting its models and hiring three new agents.
days to go:
Expired
investment:
£408,080
Chip is one of the fastest-growing Fintech companies in the UK. Chip has built an app that uses the user's banking app to make personalised decisions about their money. Its user base has doubled since its previous fundraising in 2018. The company has 153,000 accounts, and it has processed more than £130m of savings. ChipX is the company's revolutionary returns platform and it has a waiting list of more than 50,000 people. The company is a winner of the British Bank Award, 2 Crowdcube awards, and 1 World Banking Award. It has welcomed many management executives from Funding Circle, Monzo, and Purple Bricks. Chip is now scaling with market-leading returns on ChipX. It aims to build the biggest savings account in the world. With the proceeds, the company will double its team and expand ChipX in the €10 trillion European savings market.
days to go:
Expired
investment:
£3,768,260
Chip is a wealth investing & savings app that aims to foster financial prosperity for today's generation
days to go:
Expired
investment:
£5,083,686
With support from the founders of Bulldog Skincare, Zoopla and Love Film, VITL's aim is to improve the nation's health by offering vitamin packs that are fully personalised to the customer. VITL uses artificial intelligence to decipher which nutrients a person needs to ensure a healthy lifestyle. Effectively cutting out the cost of a private nutritionist.
days to go:
Expired
investment:
£908,950
Opportunity Network is a digital network that provides equal growth opportunities to Chief Executive Officers (CEO). The portal's algorithm vets prospective users, allows them to buy, sell, raise or invest in an asset, gives them the option to choose the industry they wish to do business in, and then post their requirement for the same. The user can then select the best deal for their business from a list of responses and scale profitably. The company's platform connects 32,000+ qualified CEOs in 130+ countries to $295 billion worth of commercial, financial, and mergers and acquisitions (M&A) deals. 86% of the deals on the portal find at least 1 counterpart in 48 hours. Opportunity Network aims to reach full scale by the end of 2020 and find 10 counterparts for 95% of the deals in 1 hour. The company has also been featured in publications such as Forbes, CNBC, Financial Times, and The Economist. It will use the investment to scale its business across various verticals.
days to go:
Expired
investment:
£962,500
